Expression of interleukin-11 (IL-11) and IL-11 receptor α in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells

International Journal of Oncology

Volumn 30, Issue 4, 2007, Pages 825-833

  Nakayama, Toshiyuki ^a   Yoshizaki, Ayumi ^a   Izumida, Seiya ^a   Suehiro, Tomoyuki ^a   Miura, Shiro ^a   Uemura, Takashi ^a   Yakata, Yuichi ^a   Shichijo, Kazuko ^a   Yamashita, Shunichi ^a   Sekin, Ichiro ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Gastric cancer; Interleukin 11; Interleukin 11 receptor; Phosphatidylinositol 3 kinase

Indexed keywords

ANDROSTANE DERIVATIVE; GLYCOPROTEIN GP 130; IL6ST PROTEIN, HUMAN; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CHEMISTRY; CHEMOTAXIS; DRUG EFFECT; HUMAN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STOMACH TUMOR; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; ANDROSTADIENES; CHEMOTAXIS; CYTOKINE RECEPTOR GP130; HUMANS; INTERLEUKIN-11; INTERLEUKIN-11 RECEPTOR ALPHA SUBUNIT; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RECOMBINANT PROTEINS; STOMACH NEOPLASMS; UP-REGULATION;

EID: 34247855977     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.4.825     Document Type: Article

References (53)

1. Neugut AI, Hayek M and Howe G: Epidemiology of gastric cancer. Semin Oncol 23: 281-291, 1996.
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
3. Ming SC: Pathology of the Gastrointestinal Tract. 2nd edition. Ming SC and Goldman H (eds). Williams & Wilkins, Baltimore, MD, pp632-633, 1998.
4. Goseki N, Koike M and Yoshida M: Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer 69: 1088-1093, 1992.
5. Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O'Hara RM Jr, Leary AC, Sibley B, Clark SC, Williams DA and Yang YC: Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 87: 7512-7516, 1990. (Pubitemid 20341746)
6. Du X and Williams DA: Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89: 3897-3908, 1997. (Pubitemid 27220932)
7. Reddy KB, Nabha SM and Atanaskova N: Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22: 395-403, 2003. (Pubitemid 36791895)
8. Keller DC, Du XX, Srour EF, Hoffman R and Williams DA: Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 82: 1428-1435, 1993. (Pubitemid 23263958)
9. Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L and Martin TJ: Interleukin-11 receptor signaling is required for normal bone remodeling. J Bone Miner Res 20: 1093-1102, 2005. (Pubitemid 40863797)
10. Keith JC Jr, Albert L, Sonis ST, Pfeiffer CJ and Schaub RG: IL-11, a pleiotrophic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 12 (suppl 1): 79-90, 1994.
11. Potten CS: Interleukin-11 protects the clonogenic stem cells in murine small intestinal crypts from impairment of their reproductive capacity by radiation. Int J Cancer 62: 356-361, 1995.
12. Orazi A, Du X, Yang Z, Kashai M and Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75: 33-42, 1996. (Pubitemid 26250271)
13. Kiessling S, Muller-Newen G, Leeb SN, Hausmann M, Rath HC, Strater J, Spottl T, Schlottmann K, Grossmann J, Montero-Julian FA, Scholmerich J, Andus T, Buschauer A, Heinrich PC and Rogler G: Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. J Biol Chem 279: 10304-10315, 2004.
14. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F and Graeve L: Interleukin-6 type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998. (Pubitemid 28448572)
15. Dahmen H, Horsten U, Kuster A, Jacques Y, Minvielle S, Kerr IM, Ciliberto G, Paonessa G, Heinrich PC and Muller-Newen G: Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem J 331: 695-702, 1998.
16. Berger LC, Hawley TS, Lust JA, Goldman SJ and Hawley RG: Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukin 6 and 11. Biochem Biophys Res Commun 202: 596-605, 1994. (Pubitemid 2105465)
17. Yin T, Yasukawa K, Taga T, Kishimoto T and Yang YC: Identification of a 130 kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. Exp Hematol 22: 467-472, 1994. (Pubitemid 24150367)
18. Yin T and Yang YC: Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor and oncostatin M in mouse 3T3-L1 cells. J Biol Chem 269: 3731-3738, 1994. (Pubitemid 24237702)
19. Fuhrer DK and Yang YC: Activation of src-family protein tyrosine kinases and phosphatidylinositol-3 kinase in 3T3-L1 mouse preadipocytes by interleukin-11. Exp Hematol 24: 195-203, 1996.
20. Fuhrer DK and Yang YC: Complex formation of JAK2 with PP2A, PI3K, and yes in response to hematopoietic cytokine interleukin-11. Biochem Biophys Res Commun 224: 289-296, 1996.
21. Dimitriadis E, Stoikos C, Tan YL and Salamonsen LA: Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine sgnaling 3 (SOCS3) regulate human endometrial stromal cell differentiation. Endocrinology 147: 3809-3817, 2006. (Pubitemid 44079385)
22. Fenoglio-Preser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Listrom MB and Rilke FO: The neoplastic stomach. In: Gastrointestinal Pathology. An Atras and Text. 2nd edition. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Listrom MB and Rilke FO (eds). Lippincott-Raven, Philadelphia, PA, pp237-274, 1999.
23. Goseki N, Takizawa T and Koike M: Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut 33: 606-612, 1992.
24. Nishi M, Omori Y and Miwa K (eds): Japanese Classification of Gastric Cancer. Japanese Research Society for Gastric Cancer. Kanehara & Co., Ltd., Tokyo, 1995.
25. Watanabe H, Jass JR and Sabin LH: Histological typing of oesophageal and gastric tumors. World Health Organization international histological classification of tumors. Springer, Berlin, pp20-26, 1989.
26. Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM and Todd IP: The grading of rectal cancer: histological perspective and a multivariate analysis of 447 cases. Histopathology 10: 437-459, 1986. (Pubitemid 16039125)
27. Seefeld PH and Bargen JA: The spread of cancer of the rectum: invasion of the lymphatics, veins and nerves. Ann Surg 118: 76-89, 1943.
28. Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ and Morson BC: Invasion of veins by carcinoma of rectum: methods of detection, histological features and significance. Histopathology 5: 141-163, 1981. (Pubitemid 11039331)
29. Berry MN, Edwards AM and Barritt GJ: High-yield preparation of isolated hepatocytes from rat liver. In: Isolated Hepatocytes: Preparation, Properties and Applications. Burdon RH and Knippenberg PH (eds). Elsevier, Amsterdam, pp15-58, 1991.
30. Maier R, Ganu V and Lotz M: Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 268: 21527-21532, 1993. (Pubitemid 23320641)
31. Booth C and Potten C: Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 28: 581-594, 1995. (Pubitemid 26018248)
32. Yang YC: Interleukin 11: an overview. Stem Cells 11: 474-486, 1993.
33. Minshall E, Chakir J, Laviolette M, Molet S, Zhu Z, Olivenstein R, Elias JA and Hamid Q: IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J Allergy Clin Immunol 105: 232-238, 2000. (Pubitemid 30109034)
34. Morris JC, Neben S, Bennett F, Finnerty H, Long A, Beier DR, Kovacic S, McCoy JM, Di Blasio-Smith E, La Vallie ER, Caruso A, Calvetti J, Morris G, Weich N, Paul SR, Crosier PS, Turner KJ and Wood CR: Molecular cloning and characterization of murine interleukin-11. Exp Hematol 24: 1369-1376, 1996.
35. Drewinko B, Romsdahl MM, Yang LY, Finnerty H, Long A, Beier DR, Kovacic S, McCoy JM, Di Blasio-Smith E, La Vallie ER, Caruso A, Calvetti J, Morris G, Weich N, Paul SR, Crosier PS, Turner KJ and Wood CR: Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res 36: 467-475, 1976.
36. Chen TR, Hay RJ and Macy ML: Karyotype consistency in human colorectal carcinoma cell lines established in vitro. Cancer Genet Cytogenet 6: 93-117, 1982.
37. Trainer DL, Kline T, McCabe FL, Faucette LF, Feild J, Chaikin M, Anzano M, Rieman D, Hoffstein S, Li DJ, Gennaro D, Buscarino C, Lynch M, Poste G and Grieg R: Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287-296, 1988.
38. Brader S and Eccles SA: Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis. Tumori 90: 2-8, 2004.
39. Fang JY and Richardson BC: The MAPK signalling pathways and colorectal cancer. Lancet Oncol 6: 322-327, 2005.
40. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P and Marra F: Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 276: 9945-9954, 2001.
41. Delehedde M, Sergeant N, Lyon M, Rudland PS and Fernig DG: Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways. Eur J Biochem 268: 4423-4429, 2001.
42. Tanimura S, Nomura K, Ozaki K, Tsujimoto M, Kondo T and Kohno M: Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility. J Biol Chem 277: 28256-28264, 2002.
43. Tu Y, Gardner A and Lichtenstein A: The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 60: 6763-6770, 2000.
44. Gerszten RE, Friedrich EB, Matsui T, Hung RR, Li L, Force T and Rosenzweig A: Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions. J Biol Chem 276: 26846-26851, 2001.
45. Comer FI and Parent CA: PI 3-kinases and PTEN: how opposites chemoattract. Cell 109: 541-544, 2002.
46. Curnock AP, Logan MK and Ward SG: Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 105: 125-136, 2002.
47. Stephens L, Ellson C and Hawkins P: Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr Opin Cell Biol 14: 203-213, 2002.
48. Demetri GD: Targeted approaches for the treatment of thrombocytopenia. Oncologist 6 (suppl 5): 15-23, 2001.
49. Greenwood-Van Meerveld B, Tyler K and Keith JC Jr: Recombinant human interleukin-11 modulates ion transport and mucosal inflammation in the small intestine and colon. Lab Invest 80: 1269-1280, 2000.
50. Du XX, Doerschuk CM, Orazi A and Williams DA: A bone marrow stromal-cell derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83: 33-37, 1994.
51. Venkova K, Keith JC Jr and Greenwood-van Meerveld B: Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats. J Pharmacol Exp Ther 308: 206-213, 2004.
52. Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, Schulzke JD, Boerner N, Kueppers B, Emmrich J, Mescheder A, Schwertschlag U, Shapiro M and Stange EF: Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease. Am J Gastroenterol 101: 793-797, 2006.
53. Zhang XG, Gu JJ, Lu Z, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R and Klein B: Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 179: 1337-1342, 1994.